1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Eloxx Pharmaceuticals Inc (ELOX)
  7. Quote


Eloxx Pharmaceuticals Stock Price

0.00 (0.0%)
Volume 0
Bid Price 0.7199
Ask Price 0.77
News -
Day High


52 Week Range


Day Low
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Eloxx Pharmaceuticals Inc ELOX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.7199 05:27:37
Open Price Low Price High Price Close Price Prev Close
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.7199 USD


Draw Mode:

Eloxx Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 62.09M 86.25M 73.40M $ - $ - -0.86 -0.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 22.80%

more financials information »

Eloxx Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ELOX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.660.760.63140.7102474694,3570.05999.08%
1 Month1.451.510.63140.87311221,054,261-0.7301-50.35%
3 Months1.551.890.63141.27729,157-0.8301-53.55%
6 Months1.642.530.63141.641,124,044-0.9201-56.1%
1 Year2.936.770.63141.78833,357-2.21-75.43%
3 Years15.0916.830.63142.59352,464-14.37-95.23%
5 Years10.3524.600.63143.44312,790-9.63-93.04%

Eloxx Pharmaceuticals Description

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel ribonucleic acid (RNA)-modulating drug candidates that are formulated to treat rare and ultra-rare premature stop codon diseases. The ELX-02, the company's lead investigational drug product candidate, is a small molecule designed to restore the production of full-length functional proteins. The ELX-02, is in the early stages of clinical development for systemic administration for cystic fibrosis and cystinosis.

Your Recent History
Eloxx Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.